Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Indonesia To Issue Compulsory Licenses For HIV, Hepatitis B Drugs Still Under Patent

“The Indonesian government hopes to implement one of the largest ever examples of ‘compulsory licensing,’ which will enable the generic manufacture of drugs still under patent,” IRIN reports. “Under the World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPS), countries can override patents for public health purposes by…

India’s Supreme Court Rules Against Novartis AG In ‘Landmark’ Patent Case

“India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines,” the Associated Press reports. “Novartis had…

Reuters Examines Implications Of India’s Novartis Patent Ruling For Big Pharma

Reuters examines the implications of India’s Supreme Court ruling to overturn a patent on Novartis’s cancer treatment Glivec for the pharmaceutical industry in India and across the developing world. “Stung by a landmark patent defeat, Western drug makers will be wary about launching new products in India, but they cannot…

Five Japanese Drug Makers Form PPP To Accelerate Development Of Drugs, Vaccines For Infectious Diseases

“Five Japanese pharmaceutical giants are teaming up with the Bill & Melinda Gates Foundation and Japan’s government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries,” GENNews reports (4/8). “The Global Health Innovative Technology (GHIT) fund will see Takeda, Astellas, Daiichi-Sankyo, Eisai and Shionogi partner with [the] non-profit…

International Organization Leaders Discuss Medical Innovation At Symposium

“The leaders of three top international organizations in Geneva last week discussed synergies in public health and called for increased collaboration and creativity to [improve] medical innovation,” Intellectual Property Watch reports. “The directors general of the WHO, World Trade Organization and World Intellectual Property Organization addressed the [July 5] opening…

Obama Administration Backs Away From Anti-Tobacco Efforts Under TPP Proposal, The Hill Reports

“The Obama administration is backing away from plans to protect U.S. tobacco-control measures from legal challenges under a pending Pacific trade deal, earning the wrath of public health groups,” The Hill’s “Global Affairs” blog reports. “The Office of the U.S. Trade Representative (USTR) last year suggested creating a ‘safe harbor’…

U.S. Trade Officials Should Side With Public Health In Trade Negotiations

“Give thanks to Malaysia for heading off, at least temporarily, an American effort to weaken the ability of countries to impose stiff rules on the sale of cigarettes and other tobacco products within their own borders,” a New York Times editorial states, noting, “The Malaysian proposal to preserve that ability…

IPS Examines Debate Surrounding TPP Trade Agreement Tobacco Regulation Proposals

“Between concluding rounds of negotiations towards the Trans-Pacific Partnership (TPP), a major U.S.-proposed free trade agreement, a divisive fight has heated up over the extent to which countries should be allowed to regulate the sale of foreign — potentially far cheaper — tobacco products,” Inter Press Service reports. “In dueling…

MSF Webcast Examines Issues Of Access To Medicines

Médecins Sans Frontières/Doctors Without Borders (MSF) features an archived webcast from September 5 of “a short preview and discussion of [the new documentary] ‘Fire In The Blood’ and current U.S. government trade and global health policies, with expert panelists, including the film’s director, as they examine this history and explain…